Information:
Error:
ID
22075
Description
Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00415363
Link
https://clinicaltrials.gov/show/NCT00415363
Keywords
Versions (1)
- 5/18/17 5/18/17 -
Uploaded on
May 18, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Non Small Cell Lung Cancer NCT00415363
Eligibility Non Small Cell Lung Cancer NCT00415363
- StudyEvent: Eligibility
Similar models
Eligibility Non Small Cell Lung Cancer NCT00415363
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Lung Carcinoma Metastatic in the Brain
Item
having radiologically proven brain metastases of lung cancer
boolean
C1334441 (UMLS CUI [1])
Whole brain radiotherapy | Gray unit of radiation dose Quantity Week Quantity | enzastaurin
Item
having received whole brain radiotherapy with either 30 grays in 2 weeks or 20 grays in one week. treatment with enzastaurin must start within 14 days after the last fraction of the whole brain radiotherapy
boolean
C1520143 (UMLS CUI [1])
C0556636 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0439230 (UMLS CUI [2,3])
C1265611 (UMLS CUI [2,4])
C1327830 (UMLS CUI [3])
C0556636 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0439230 (UMLS CUI [2,3])
C1265611 (UMLS CUI [2,4])
C1327830 (UMLS CUI [3])
Radiotherapy to brain | Radiosurgery Quantity
Item
no other previous radiotherapy to the brain except for radiosurgery at one occasion
boolean
C0948319 (UMLS CUI [1])
C0085203 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0085203 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Organ function Laboratory Procedures
Item
adequate organ function as measured by appropriate laboratory tests.
boolean
C0678852 (UMLS CUI [1,1])
C0022885 (UMLS CUI [1,2])
C0022885 (UMLS CUI [1,2])
Age
Item
age 18 years or older.
boolean
C0001779 (UMLS CUI [1])
Able to swallow Tablets | Condition Interferes with Oral medication administration | Vomiting | Partial bowel obstruction
Item
inability to swallow tablets or show conditions which could interfere with oral medication intake (e.g. vomiting, partial bowel obstruction).
boolean
C2712086 (UMLS CUI [1,1])
C0039225 (UMLS CUI [1,2])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0001563 (UMLS CUI [2,3])
C0042963 (UMLS CUI [3])
C1328480 (UMLS CUI [4])
C0039225 (UMLS CUI [1,2])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0001563 (UMLS CUI [2,3])
C0042963 (UMLS CUI [3])
C1328480 (UMLS CUI [4])
Antiepileptic Agents Unable to discontinue | Carbamazepine | Phenobarbital | Phenytoin
Item
inability to discontinue use of certain anti-epileptic drugs such as, carbamazepine, phenobarbital or phenytoin.
boolean
C0003299 (UMLS CUI [1,1])
C1548265 (UMLS CUI [1,2])
C0006949 (UMLS CUI [2])
C0031412 (UMLS CUI [3])
C0031507 (UMLS CUI [4])
C1548265 (UMLS CUI [1,2])
C0006949 (UMLS CUI [2])
C0031412 (UMLS CUI [3])
C0031507 (UMLS CUI [4])
Warfarin
Item
concurrent administration of warfarin
boolean
C0043031 (UMLS CUI [1])
Hemophilia
Item
hemophilia
boolean
C0684275 (UMLS CUI [1])
Cancer treatment Systemic
Item
having had any systemic anti-cancer treatment within the last 2 weeks prior to enrolment.
boolean
C0920425 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0205373 (UMLS CUI [1,2])